Toggle menu

The Prior Study

Start date:
June 2017
End date:
August 2017
Co-ordinated by:
EMERGE, RIE
Main trial site:
RIE

Fluid exchange is an area where more research is required, in particular the role of pore size and membrane osmotic pressure (MOP). The main objective of this study is to plot the MOP and Mean arterial pressure (MAP) of healthy participants onto a chart that has been created from previous work. This chart could act as a diagnostic tool to give individualised treatment to patients in shock. The secondary objectives are to see if it is possible to calculate MOP from biochemistry results and to create a chart plotting pore size against MOP.

This is an observational study looking to recruit 20 ‘healthy’ participants from staff employed at the RIE. Two blood samples will be taken. One sample will be sent to the labs for biochemistry testing. The second sample will be retained in order to measure MOP. Participant information taken would be minimal but include blood pressure reading and past medical history. No follow-up will be required.

Chief Investigator

Dr Gareth Clegg

Senior Lecturer at the University of Edinburgh & Honorary Consultant in Emergency Medicine

Research Team

Dr Frank Prior PhD

Pharmacist

Allan MacRaild

Stroke Lead Research Nurse

Related news

The Prior Study

The Prior Study

19 Jul 2017 | Allan MacRaild

EMERGE and RRG are undertaking a preliminary study into the principles of fluid exchange within the body.

Read more

More EMERGE Trials

EHA - Epidemiological analysis for the Hereditary Angioedema Disease is an international, multicentre, epidemiological study that aims to explore the feasibility of a new Dried Blood Spot (DBS) filtercard-based screening algorithm and thereby the prevalence of the Hereditary Angioedema.

Read more

EHA Study

EHA - Epidemiological analysis for the Hereditary Angioedema Disease

Global Anticoagulant Registry in the FIELD observing treatment and outcomes in patients with treated acute Venous Thromboembolic Events in the real world

Read more

Garfield-VTE

Global Anticoagulant Registry In the FIELD – Venous Thromboembolic Events

Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.

Read more

NOVEL Study

Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions